Marya Postner


+1 650 843 5081

Marya Postner represents public and private life sciences companies, especially biotechnology and biopharmaceutical companies, in a variety of transactions. She counsels clients with respect to the structuring and negotiation of agreements designed to maximize the value of the company's products and technology assets. She has particular experience handling strategic alliances between biotechnology and pharmaceutical companies in areas as diverse as collaborative research and the development and marketing of late-stage pharmaceutical products.  Marya also has substantial technical expertise in the fields of genetics, developmental biology and cell biology. As a graduate student in Princeton University's Department of Molecular Biology, she investigated the role of the cytoskeleton in nuclear division and membrane partitioning, and she co-authored several scientific publications based on this work.

Download full bio


  • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals 

  • Iconic Therapeutics Series C Financing 

  • Alder Biopharmaceuticals $80 Million Initial Public Offering 

  • Medivation Expanding Oncology Franchise with Acquisition of Talazoparib from BioMarin 

  • Bristol Meyers Enters Agreement with Five Prime 

  • View all


  • University of California, Berkeley School of Law (Boalt Hall)
    JD, 1996

  • Princeton University
    PHD, Molecular Biology

  • Princeton University
    MA, Molecular Biology

  • Georgetown University
    BS, Biology
    magna cum laude, 1987

Admissions & Credentials


Registered to practice before the United States Patent & Trademark Office (USPTO)


  • American Bar Association

  • Sigma Xi

  • American Association for the Advancement of Science


+1 650 843 5081 office
+1 650 849 7400 fax

3175 Hanover Street
Palo Alto, CA 94304-1130